Completed
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
NCT00130195
- Conditions
- Acute Lymphoblastic Leukemia, Chromosome Aberrations, Hematologic Diseases, +14 more
- Locations
-
- Department of Hematology, Nagoya University Graduate School of Medicine Nagoya, Japan